Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain MESO message board posts where the ticker symbol MESO has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

Related news from
Wed, 21 Feb 2018
23:00:01 +0000
Mesoblast stem cell therapy meets goal of pediatric Graft vs Host study
The study tested Mesoblast's off-the-shelf stem cell product, remestemcel-L, in 55 children who did not respond to steroids after a bone marrow transplant triggered acute Graft Versus Host Disease (aGVHD). On day 28 after receiving the first dose of remestemcel-L, 69 percent of children had experienced a complete or partial response, deemed a statistically significant increase over historical expectations of about 45 percent, according to data presented at a medical meeting.
Wed, 21 Feb 2018
23:00:00 +0000
Primary Endpoint Successfully Achieved in Mesoblast’s Phase 3 Cell Therapy Trial for Acute Graft Versus Host Disease
NEW YORK and MELBOURNE, Australia, Feb. 21, 2018-- Mesoblast Limited today announced that the Phase 3 trial of its allogeneic mesenchymal stem cell product candidate MSC-100-IV in children with steroid ...
Tue, 20 Feb 2018
02:08:31 +0000
Is Mesoblast Limited’s (ASX:MSB) CEO Pay Fair?
Silviu Itescu took the reins as CEO of Mesoblast Limited’s (ASX:MSB) and grew market cap to AU$641.19M recently. Recognizing whether CEO incentives are aligned with shareholders is a crucial partRead More...
Mon, 12 Feb 2018
06:49:07 +0000
Breaking Down Mesoblast Limited’s (ASX:MSB) Ownership Structure
In this analysis, my focus will be on developing a perspective on Mesoblast Limited’s (ASX:MSB) latest ownership structure, a less discussed, but important factor. Ownership structure of a company hasRead More...
Sat, 03 Feb 2018
03:51:10 +0000
What Is The Future Prospect For Healthcare And Mesoblast Limited (ASX:MSB)?
Mesoblast Limited (ASX:MSB), a A$629.45M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population and the growingRead More...
Thu, 18 Jan 2018
00:02:21 +0000
Best Growth Stocks To Buy
Looking to add potential meaningful upside to your portfolio, but unsure where to start? Stocks such as MNF Group and Mesoblast are considered to be high growth in terms ofRead More...
Thu, 11 Jan 2018
11:00:00 +0000
Mesoblast to Present at 36th Annual J.P. Morgan Healthcare Conference
NEW YORK and MELBOURNE, Australia, Jan. 11, 2018-- Mesoblast Limited will present a corporate update at the 36 th annual J.P. Morgan Healthcare Conference being held in San Francisco this week. The presentation ...
Thu, 28 Dec 2017
17:23:55 +0000
ETFs with exposure to Mesoblast Ltd. : December 28, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mesoblast Ltd. Here are 5 ETFs with the largest exposure to MESO-US. Comparing the performance and risk of Mesoblast Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more <b>(Read more...)</b>
Thu, 21 Dec 2017
11:00:00 +0000
Mesoblast Receives FDA Regenerative Medicine Advanced Therapy Designation for Its Cell Therapy in Heart Failure Patients With Left Ventricular Assist Devices
NEW YORK and MELBOURNE, Australia, Dec. 21, 2017-- Mesoblast Limited today announced that the United States Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation for ...
Thu, 21 Dec 2017
04:58:27 +0000
FDA to fast track Mesoblast's cell therapy for heart failure
Australian drug developer Mesoblast Ltd said on Thursday the U.S. Food and Drug Administration would fast track the review of its cell therapy treatment for heart failure patients under a new designation rolled out last December. Mesoblast's mesenchymal precursor cell (MPC) therapy, aiming to mitigate advanced heart failure, received the FDA's Regenerative Medicine Advanced Therapy (RMAT) designation, the company said.
Wed, 20 Dec 2017
11:00:00 +0000
Mesoblast’s Phase 3 Trial in Children With Acute Graft Versus Host Disease Completes Enrollment
NEW YORK and MELBOURNE, Australia, Dec. 20, 2017-- Mesoblast Limited today announced that the Phase 3 trial of its proprietary allogeneic mesenchymal stem cell product candidate MSC-100-IV in children ...
Mon, 18 Dec 2017
12:50:00 +0000
Wired News – TiGenix Received an Exclusive Global Patent License to Cx601 from Mesoblast in the Local Treatment of Fistulae
Stock Monitor: Peregrine Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 18, 2017 / Active-Investors issued a free report on Mesoblast Ltd (NASDAQ: MESO ), which is readily accessible ...
Mon, 18 Dec 2017
12:00:00 +0000
Tiny stem cell companies close in on major heart disease goals
The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011. Both have overcome major hurdles to manufacturing stem cell treatments on a large scale that are off-the-shelf products derived from healthy donor bone marrow and do not face immune system rejection issues. Cleveland-based Athersys, with a market value of about $200 million, demonstrated evidence in a midstage trial that its therapy may be able to expand the emergency treatment window for major strokes to up to 36 hours, compared with about four hours with current drugs, potentially allowing many more patients to avoid crippling disabilities.
Fri, 15 Dec 2017
00:34:46 +0000
Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae
NEW YORK and MELBOURNE, Australia and LEUVEN, Belgium, Dec. 14, 2017-- Mesoblast Limited and TiGenix NV today announce that Mesoblast has granted TiGenix exclusive access to certain of its patents to support ...
Thu, 14 Dec 2017
01:28:02 +0000
What You Must Know About Mesoblast Limited’s (ASX:MSB) Financial Health
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Mesoblast Limited (ASX:MSB), as the company does not have to adhere to strict debt covenants. However, it also faces higherRead More...
Mon, 11 Dec 2017
11:00:00 +0000
Mesoblast Named Global Technology Leader in Cell Therapy Industry
Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry.
Thu, 16 Nov 2017
14:01:02 +0000
Caterpillar, Avon Products, JA Solar Holdings, Mesoblast and 21Vianet Group highlighted as Zacks Bull and Bear of the Day
Caterpillar, Avon Products, JA Solar Holdings, Mesoblast and 21Vianet Group highlighted as Zacks Bull and Bear of the Day



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "At VF I have met some of the greatest givers from all walks of life and from all parts of the world. I thank each of them for sharing part of their life and knowledge with me." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards